Status:
COMPLETED
Nebulized Procaterol Versus Nebule Salbutamol for the Treatment of Moderate Acute Asthma
Lead Sponsor:
PT Otsuka Indonesia
Conditions:
Moderate Acute Asthma
Eligibility:
All Genders
15-60 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the efficacy and safety of nebule procaterol with nebule salbutamol in the treatment of moderate acute asthma.
Eligibility Criteria
Inclusion
- Patients with moderate acute asthma according to Global Initiative for Asthma (GINA) 1998 (Appendix 1). Patients with moderate acute asthma according to Modified Global Initiative for Asthma (GINA) 1998 (Patients with asthma score 5 - 11; PEFR ≤ 80% predicted)
- Patients of both gender aged 15 to 60 years
- Patients still have the ability to undergo examinations and give written informed consent
Exclusion
- Pregnant and lactating women
- Smokers
- Patients with heart disease, hyperthyroidism, diabetes mellitus, COPD or other chronic diseases
- Patients with signs of severe infections
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00990847
Start Date
June 1 2007
End Date
August 1 2008
Last Update
October 7 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Indonesia/ Persahabatan Hospital
Jakarta, Indonesia